BAT CEO Warns Disposable E-Cigarette Ban Will Backfire

BAT by 2FIRSTS, edited by Sophia
Mar.26.2024
BAT CEO Warns Disposable E-Cigarette Ban Will Backfire
BAT CEO Tadeu Marroco believes the UK government's plan to ban disposable e-cigarettes will have unintended consequences.

According to a report by the BBC on March 25, Tadeu Marroco, the CEO of British American Tobacco (BAT), stated that banning disposable e-cigarettes would not be effective and that raising the smoking age limit would have "unintended consequences.

 

The British government plans to ban the sale of disposable e-cigarettes starting in April of next year, in what is being touted as the biggest public health measure in decades. Currently, BAT is the third largest e-cigarette sales company in the UK. Sales of disposable e-cigarettes have surged in recent years, with projections indicating that annual sales could reach into the billions, many of which are being sold illegally.

 

The British government announced a tobacco and e-cigarette law last week, which will prohibit individuals born after 2009 from purchasing tobacco and impose on-the-spot fines for retailers selling to those under 18.

 

However, Maroko stated that similar bans in other countries have not achieved the desired results. He said:

 

In other countries, the effectiveness of this policy is not ideal. In Australia, for example, a complete ban has led to high levels of purchases by teenagers in the illegal market, and Brazil has experienced a similar situation.

 

Deborah Arnott, Chief Executive of the anti-smoking charity organization Action on Smoking and Health (ASH), has expressed opposition to the ban on disposable products, stating that while it is feasible, strict regulation is necessary not only within shops but also to prevent illegal imports.

 

BAT, one of the largest publicly traded companies in the UK, ranks third in the disposable e-cigarette market. Chinese companies SKE and Heaven Gifts are the market leaders, manufacturing e-cigarette products including ELFBAR and Lost Mary.

 

Maroko agreed that stricter punishment measures are needed. He stated that the proposed on-the-spot fine of £100 "is not enough" and called for the implementation of France's proposed €100,000 (approximately £86,000) "appropriate fine".

 

However, he issued a warning against the government's plan to raise the legal smoking age limit each year, stating that those born in 2009 and later will never be able to legally purchase tobacco, which will have "unintended consequences" for retail and enforcement.

 

"We first need to address the issue of minors using e-cigarettes. We need to have retail licenses, just like we do for alcohol products," he reiterated the company's call to ban flavors that appeal to children, such as dessert and soft drink flavors.

 

When asked whether BAT only supports policies that align with the company's interests, the CEO replied, "This is an industry that has been under close scrutiny on how to reduce the impact of our products on health... This is the first time we have the technology to do this."

 

Mr. Marlboro defended the company's sponsorship activities, stating that they were "primarily targeted at adults" as they distributed free samples of their oral nicotine pouch products for promotional purposes. "We are very careful about this," he said. The UK Tobacco and E-cigarette Act will grant the government the power to regulate the sale of nicotine pouches.

 

When asked if the company has a say in regulating e-cigarettes, Mr. Maloco did not comment, but he said, "We have already discussed these issues in detail in the past, and they are now in the past...BAT now has the opportunity to reduce the risks of our products, which was not possible in the past."

 

Mrs. Arnot from ASH stated:

 

We have heard BAT say many times that they have changed, but BAT is still promoting traditional tobacco cigarettes...most of their profits still come from this. This is why they don't like government sales age legislation, not because it is ineffective, but because it is effective.

 

In a statement, the Department of Health and Social Care stated that approximately 80,000 people in the UK die from smoking each year, leading to a loss of £17 billion annually. The Tobacco and E-cigarette Bill is the largest public health measure in recent decades, aiming to protect future generations from the harm of smoking. It is expected to save thousands of lives and billions of pounds for our National Health Service, freeing up new resources to improve the overall health of the UK.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
Chinese authorities have disclosed the country’s first reported criminal case involving counterfeit vapes marketed as “medical nebulizers” and “zero-nicotine” products. Authorities determined that the products involved were counterfeit vapes and pursued criminal charges for producing and selling counterfeit goods. According to the report, the case resulted in the seizure of 347,000 counterfeit vape pods and 53,700 vape devices, with physical goods valued at 22.13 million yuan.
Aug.04
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
JNR has introduced the Shisha Hookah 70K, a high-capacity rechargeable disposable vape designed around a hookah-inspired experience. The device comes prefilled with 60ml of e-liquid at 6mg/ml (0.6%) nicotine strength, alongside a 1,000mAh rechargeable battery and a 0.38Ω single mesh coil. It also features adjustable airflow and battery and e-liquid level displays. JNR claims the device can deliver up to 70,000 puffs and offers more than 20 flavors. Retail listings for the product have appeared in markets including Tunisia.
Market
Aug.24 by 2Firsts Perspectives
Italy and Greece Oppose Ireland’s Nicotine Product Bill, Raising EU Regulatory Concerns
Italy and Greece Oppose Ireland’s Nicotine Product Bill, Raising EU Regulatory Concerns
Italy and Greece have opposed Ireland’s proposed nicotine product regulations, arguing that the measures could affect EU market coordination and the free movement of products. Ireland plans to introduce stricter rules covering nicotine products including vapes and nicotine pouches, with measures involving packaging, marketing and sales controls. The dispute highlights differences among EU member states between stronger public health protections and maintaining regulatory consistency within the bloc’s single market.
Jul.29
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives